Navigation Links
Unilife Commences U.S. Sales of Unitract® 1mL Syringes

LEWISBERRY, Pa., Nov. 15, 2010 /PRNewswire/ -- Unilife Corporation ("Unilife" or "Company") (Nasdaq: UNIS; ASX: UNS) today announced that it has commenced U.S. sales of its Unitract® range of 1mL safety syringes.

Unilife and Independent Medical Co-Op, Inc. ("IMCO"), one of the largest medical supply co-operatives in the U.S., have entered into a preferred, non-exclusive marketing program for the sale of Unitract 1mL syringes to U.S. healthcare facilities.

IMCO's member distributors provide medical equipment and supplies to healthcare facilities across the U.S. and Canada. Many of IMCO's Members focus primarily on the physician and long-term care markets. These two segments of the U.S. healthcare market consume a significant proportion of all 1mL safety syringes manufactured each year.

Unilife considers IMCO to be an ideal partner to support the initial launch of its Unitract range of 1mL syringes in the U.S. It is now processing for shipment a number of initial purchase orders it has received from IMCO member distributors. Discussions with a number of additional IMCO members are currently under way as part of an integrated nationwide launch for the Company's FDA-certified range of products.

Mr. Alan Shortall, CEO of Unilife, stated, "Unilife is delighted to announce the commencement of U.S. sales and shipments for its Unitract range of 1mL syringes. It is appropriate that U.S. sales have commenced in the same month that healthcare industry leaders are celebrating the 10-year anniversary of the signing of the Federal Needlestick Safety and Prevention Act. Despite these laws mandating the use of safety syringes within U.S. healthcare facilities, many healthcare workers continue to remain at risk of needlestick injury, including injuries from existing safety syringe technologies.  We believe the automatic and operator controlled safety features that are fully integrated within the barrel of our Unitract range of 1mL syringes make them ideally positioned to help address the unmet needs of healthcare workers.

"IMCO is ideally positioned to act as a preferred partner to support our initial launch activities, given their focus and market reach within those healthcare sectors where the use of 1mL safety syringes is greatest. We look forward to working with IMCO and their members to successfully introduce our Unitract 1mL syringes to healthcare facilities across the U.S."  

Mr. Bill McLaughlin, CEO of IMCO stated, "Unilife's line of retractable syringes is outstanding in every way and will clearly become an important factor in the market, improving the quality of patient care and the personal safety of clinicians everywhere".

The Unitract range of 1mL syringes is the world's first and only known syringe that allows operators to control the speed of automatic needle retraction directly from the patient's body into the barrel of the syringe where it is locked in place. The products, which include insulin and tuberculin variants with a five-year shelf life, are well positioned to help prevent the transmission of blood-borne diseases such as HIV and hepatitis C via needlestick injuries, aerosol dispersal and syringe reuse. Primary target markets of the products include healthcare facilities, pharmaceutical companies and patients who self-administer prescription medication. Further information on the products is available at

Production of the Unitract 1mL Insulin Syringe at Unilife's FDA-registered facility in Pennsylvania is occurring on a fully automated assembly system which the Company designed, developed and built using in-house expertise. A video of this automated production system can be viewed at

Distributors and healthcare facilities seeking further information about the Unitract range of 1mL safety syringes or a free sample kits can phone +1 717 938 9323 or email

About Unilife CorporationUnilife Corporation is a U.S.-based medical device company focused on the design, development, manufacture and supply of a proprietary range of retractable syringes. Primary target customers for Unilife products include pharmaceutical manufacturers, suppliers of medical equipment to healthcare facilities and patients who self-administer prescription medication. These patent-protected syringes incorporate automatic and fully-integrated safety features which are designed to protect those at risk of needlestick injuries and unsafe injection practices. Unilife is ISO 13485 certified and has FDA-registered medical device manufacturing facilities in Pennsylvania.

This press release contains forward-looking statements. All statements that address operating performance, events or developments that we expect or anticipate will occur in the future are forward-looking statements. These forward-looking statements are based on management's beliefs and assumptions and on information currently available to our management. Our management believes that these forward-looking statements are reasonable as and when made. However, you should not place undue reliance on any such forward-looking statements because such statements speak only as of the date when made. We do not undertake any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. In addition, forward-looking statements are subject to certain risks and uncertainties that could cause actual results, events and developments to differ materially from our historical experience and our present expectations or projections. These risks and uncertainties include, but are not limited to, those described in "Item 1A. Risk Factors" and elsewhere in our Annual Report and 10-K and those described from time to time in other reports which we file with the Securities and Exchange Commission. 

General: UNIS-G Investor Contacts (US):Investor Contacts (Australia)Todd Fromer / Garth Russell

Stuart Fine

Jeff CarterKCSA Strategic Communications

Carpe DM Inc

Unilife CorporationPhone + 1 212-682-6300

Phone + 1 908 469 1788

Phone + 61 2 8346 6500

SOURCE Unilife Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Unilife Corporation Schedules Fiscal 2011 First Quarter Conference Call For Monday, November 15, 2010
2. Unilife Secures U.S. Government Financial Backing for the Completion of New Global Headquarters and Manufacturing Facility in York, PA
3. Unilife Corporation Secures FDA 510k Clearance for the Unitract™ 1mL Tuberculin Syringe
4. Unilife Corporation Announces Preliminary Financial Results for Fourth Quarter and Fiscal Year 2010
5. Unilife Corporation Schedules Fiscal 2010 Fourth Quarter and Year End Conference Call for Monday, August 30, 2010
6. Unilife Corporation Commences Trading on the NASDAQ Global Market Under the Ticker Symbol UNIS
7. China Cord Blood Corporation Commences Warrant Exchange Offer
8. Pfizer Commences Tender Offer for All Outstanding Shares of King Pharmaceuticals, Inc.
9. Sanofi-aventis Commences Tender Offer to Acquire All Outstanding Shares of Genzyme for $69 per Share in Cash
10. Leading Dutch Cancer Center Commences Treatments Using New TrueBeam from Varian Medical Systems
11. Al Amal Hospital in Qatar Commences Treatments Using Fast and Efficient RapidArc Radiotherapy Technology from Varian Medical Systems
Post Your Comments:
(Date:10/12/2015)... Center for Innovation announced today that Elizabeth ... th recipient of the CME Group Melamed-Arditti Innovation ... Theranos , to change health care from reactive to proactive, ... care. CME Group will present the award at the eighth ... Naples, Florida , on Tuesday, November 17. ...
(Date:10/12/2015)... PUNE, India , October 12, 2015 ... new market research report "Spirometer Market by Product (Hand-held, Table-top, ... (Hospital, Clinic, Homecare), Application, & Geography - Global Forecast to ... reach USD 858.6 Million by 2020, at a CAGR of ... data Tables and 128 F igures spread th ...
(Date:10/12/2015)... ) ... "Personalized Medicine, Targeted Therapeutics and Companion Diagnostic ... Industry Trends, Technologies, Participants, and Environment" ... ) has announced the addition of ... Companion Diagnostic Market to 2019 - Strategic ...
Breaking Medicine Technology:
(Date:10/13/2015)... NC (PRWEB) , ... October 13, 2015 , ... Scientists ... versus tissue biopsy in 18 patients with or without mesothelioma. Surviving Mesothelioma has just ... , The doctors from PhenoPath Laboratories in Seattle and the University of British ...
(Date:10/13/2015)... ... October 13, 2015 , ... ... new School of Nursing. Dr. McLeod—who earned her Doctor of Nursing Practice from ... education that has spanned four decades. , Dr. McLeod’s long and successful nursing ...
(Date:10/13/2015)... ... 13, 2015 , ... Breathing is one of the human ... According to T’ai Chi (also spelled “Taiji”) and Qigong Grand-masters Steven Aung, MD, ... with the 7,000 year old tradition they teach, can improve health, increase energy ...
(Date:10/13/2015)... ... 2015 , ... In an ongoing effort to provide the ... Texas, child development and pediatric therapy center, is working with TRICARE to emphasize ... options for receiving this kind of care for affected children. Because of concerns ...
(Date:10/13/2015)... Alpharetta, Georgia (PRWEB) , ... October 13, 2015 ... ... their leadership team: Debbie Vereb has been named the organization’s Executive Vice ... Tony Gerena, have been hired to key leadership roles in the company. , ...
Breaking Medicine News(10 mins):